Ultragenyx Pharmaceutical Inc at Evercore ISI Healthcare Conference Transcript
All right, we are going to go ahead and get started here. So, next up we have Chief Medical Officer from Ultragenyx, Eric Crombez. Eric, I am just going to turn over to you for a brief introduction where the company stands today and then we will get into it.
Yeah, so Ultragenyx, founded, very dedicated to developing and commercializing drugs for patients with disease that has been core [termination] from the beginning and we are very much fed status to that core there. Certainly a lot of success in the commercial setting led by Crysvita and very much supported by Matt Sevi of MEPSEVII, EVKEEZA, DOJOLVI, but I think, what a lot of people are looking forward to is really with the progression of our development pipeline and a lot of Phase 3 data readouts and filing in the near term. I think as far as value drivers in the near term led by osteogenesis imperfecta.
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
